Literature DB >> 19171646

Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells.

Kazuhiro Kimura1, Shinichiro Teranishi, Teruo Nishida.   

Abstract

PURPOSE: The barrier function of the corneal epithelium contributes to corneal homeostasis and is impaired by inflammation. Adherens junctions (AJs) and tight junctions (TJs) of the corneal epithelium are essential for cell adhesion and barrier function. We examined the effects of the proinflammatory cytokine interleukin (IL)-1beta on AJs and TJs as well as on barrier function in simian virus 40-transformed human corneal epithelial (HCE) cells.
METHODS: Barrier function was evaluated by measurement of transepithelial electrical resistance (TER). The subcellular distributions of the AJ proteins E-cadherin and beta-catenin, the TJ proteins ZO-1 and occludin, and the p65 subunit of nuclear factor (NF)-kappaB were determined by immunofluorescence staining. The expression of junctional proteins as well as the phosphorylation and degradation of the NF-kappaB-inhibitory protein IkappaB-alpha were examined by immunoblot analysis.
RESULTS: IL-1beta induced the disappearance of ZO-1 and occludin from the interfaces of neighboring HCE cells without affecting the localization of E-cadherin or beta-catenin. It also reduced the TER of HCE cells in a concentration- and time-dependent manner. The overall abundance of TJ and AJ proteins was not affected by IL-1beta. IL-1beta induced the phosphorylation and downregulation of IkappaB-alpha as well as the translocation of p65 to the nucleus. The NF-kappaB inhibitor curcumin blocked the effects of IL-1beta on both TER and the subcellular localization of ZO-1 and occludin.
CONCLUSIONS: IL-1beta induced the redistribution of ZO-1 and occludin from TJs of HCE cells and thereby disrupted the barrier function of these cells in a manner dependent on NF-kappaB. These effects of IL-1beta may contribute to the loss of corneal epithelial barrier function associated with ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171646     DOI: 10.1167/iovs.08-2606

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  The Altered Mucosal Barrier Function in the Duodenum Plays a Role in the Pathogenesis of Functional Dyspepsia.

Authors:  Keishi Komori; Eikichi Ihara; Yosuke Minoda; Haruei Ogino; Taisuke Sasaki; Minako Fujiwara; Yoshinao Oda; Yoshihiro Ogawa
Journal:  Dig Dis Sci       Date:  2019-01-23       Impact factor: 3.199

2.  Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal.

Authors:  Irania Alarcon; Connie Tam; James J Mun; Jeffrey LeDue; David J Evans; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability.

Authors:  Limin Wu; Servio H Ramirez; Allison M Andrews; Wendy Leung; Kanako Itoh; Jiang Wu; Ken Arai; Eng H Lo; Josephine Lok
Journal:  J Neurochem       Date:  2015-11-10       Impact factor: 5.372

4.  Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.

Authors:  Andre Okanobo; Sunil K Chauhan; Mohammad H Dastjerdi; Shilpa Kodati; Reza Dana
Journal:  Am J Ophthalmol       Date:  2012-04-26       Impact factor: 5.258

5.  Ocular tropism of influenza A viruses: identification of H7 subtype-specific host responses in human respiratory and ocular cells.

Authors:  Jessica A Belser; Hui Zeng; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.

Authors:  Hyun Soo Lee; Sunil K Chauhan; Andre Okanobo; Nambi Nallasamy; Reza Dana
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

7.  Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome.

Authors:  Ying-Ting Chen; Karina Nikulina; Stanislav Lazarev; Ahmad F Bahrami; Lisa B Noble; Marianne Gallup; Nancy A McNamara
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

Review 8.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

9.  Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Authors:  Francisco Amparo; Mohammad H Dastjerdi; Andre Okanobo; Giulio Ferrari; Leila Smaga; Pedram Hamrah; Ula Jurkunas; Debra A Schaumberg; Reza Dana
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

10.  Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer.

Authors:  Hannah R Wardill; Richard M Logan; Joanne M Bowen; Ysabella Z A Van Sebille; Rachel J Gibson
Journal:  Support Care Cancer       Date:  2015-10-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.